Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant [NA]

View source ↗

Summary

Clinical trial update on donor lymphocyte infusion for patients with recurrent or persistent hematologic cancer after donor stem cell transplant. Status complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia, Lymphoma | NA | Status: COMPLETED | Results posted: 2020-08-26